以吡唑并[1,5-α]吡啶-3-甲醛和N-甲酰基哌嗪为原料,经过还原胺化、水解和N-烷基化反应,合成了3-(4-苄基哌嗪-1-基甲基)吡唑并[1,5-α]吡啶、3-[4-(4-氯苄基)哌嗪-1-基甲基]吡唑并[1,5-α]吡啶和3-[4-(4-甲氧基苄基)哌嗪-1-基甲基]吡唑并[1,5-α]吡啶,通过1H NMR、ESI MS等技术手段对中间体及3个目标化合物进行了表征,并通过体外受体结合实验,测定3个目标化合物对多巴胺D42受体的亲和常数(K)分别为1.6、7.2、65 nmol/L;对D2受体的亲和常数分别为1920、5320和9800 nmol/L;对D3受体的亲和常数分别为1710、4270和5600 nmol/L.结果表明,3-(4-苄基哌嗪-1-基甲基)吡唑并[1,5-α]吡啶对多巴胺D4受体具有较高的亲和性与选择性,是多巴胺D4受体潜在的配基.
参考文献
| [1] | YU Lin,CAO Aihua,LV Xiaona,et al.Effect of Dopamine D4 Receptor Agonist ABT-724 on Behaviors in Rat Model of Attention-deficit Hyperactivity Disorder[J].Chinese J Behav Med Brain Sci,2011,20 (9):800-802 (in Chinese).于林,曹爱华,吕孝娜,等.多巴胺D4受体激动剂ABT-724对注意缺陷多动障碍模型大鼠行为的影响[J].中华行为医学与脑科学杂志,2011,20(9):800-802. |
| [2] | Pawel Z,Krzysztof M,Andrzej M,et al.Quinoline-and Isoquinoline-sulfonamide Derivatives of LCAP as Potent CNS Multireceptor-5-HT1a/5-HT2A/5-HT7 and D2/D3/D4-Agents:the Synthesis and Pharmacological Evaluation[J].Bioorg Med Chem,2012,20:1545-1556. |
| [3] | Takami G,Ota M,Nakashima A,et al.Effects of Atypical Antipsychotics and Haloperidol on PC12 Cells:Only Aripiprazole Phosphorylates AMP-activated Protein Kinase[J].J Neural Transm,2010,117(10):1139-1153. |
| [4] | Rostom S A.Novel Fused Pyrrole Heterocyclic Ring Systems as Structure Analogs of LE 300:Synthesis and Pharmacological Evaluation as Serotonin 5-HT2A,Dopamine and Histamine H1 Receptor Ligands[J].Arch Pharm,2010,343(2):73-80. |
| [5] | JI Weidong,ZHOU Jiaxiu,YANG Chuang,et al.The Executive Function in Han Chinese Children with Tourette's Syndrome and Its Association with the Polymorphism of DRD4 Exon Ⅲ 48bp VNTR[J].Chinese Ment Health J,2010,24(8):568-573(in Chinese).季卫东,周家秀,杨闯,等.抽动秽语综合征汉族患者的执行功能及与多巴胺D4受体第3外显子48bp可重复序列多态性[J].中国心理卫生杂志,2010,24(8):568-573. |
| [6] | Lauzon N M,Laviolette S R.Dopamine D4-receptor Modulation of Cortical Neuronal Network Activity and Emotional Processing:Implications for Neuropsychiatric Disorders[J].Behav Brain Res,2010,208 (1):12-22. |
| [7] | Stefan L,Harald H,Peter G.Synthesis and Biological Investigations of Dopaminergic Partial Agonists Preferentially Recognizing the D4 Receptor Subtype[J].Bioorg Med Chem Lett,2006,16(11):2955-2959. |
| [8] | Iris R,Gotffried S.Dopamine D4 Receptor Exon Ⅲ Polymorphism,Adverse Life Events and Personality Traits in a Nonclinical German Adult Sample[J].Neuropsycholoiology,2011,63(1):52-58. |
| [9] | Linz S,Mller J,H bner H,et al.Design,Synthesis and Dopamine D4 Receptor Binding Activities of New N-Heteroaromatic 5/6-ring Mannich Bases[J].Bioorg Med Chem,2009,17(13):4448-4458. |
| [10] | Lacivita E,De Giorgio P,Lee IT,et al.Design,Synthesis,Radiolabeling,and in vivo Evaluation of Carbon-11 Labeled N-[2-[4-(3-cyanopyridin-2-yl) piperazin-1-yl]ethyl]-3-methoxybenzamide,a Potential Positron Emission Tomography Tracer for the Dopamine D(4) Receptors[J].J Med Chem,2010,53(20):7344-7355. |
| [11] | LI Gucai,ZHANG Ru,JIANG Kaijun.Synthesis and Biological Evaluation of Indolin-2-one Derivatives as Dopamine D4 Re-ceptor Ligands[J].Chem Reag,2012,34(7):593-596(in Chinese).李谷才,张儒,蒋开军.二氢吲哚-2-酮类化合物的合成及其体外活性研究[J].化学试剂,2012,34(7):593-596. |
| [12] | Olaf P,Rainer T,Jcarsten H,et al.Synthesis,Radiofluorination,and in Vitro Evaluation of Pyrazolo[1,5-a]pyridine-based Dopamine D4 Receptor Ligands:Discovery of an Inverse Agonist Radioligand for PET[J].J Med Chem,2008,51:1800-1810. |
上一张
下一张
上一张
下一张
计量
- 下载量()
- 访问量()
文章评分
- 您的评分：
-
10%
-
20%
-
30%
-
40%
-
50%